2MBBS, Msc Public Health, Specialist Family Medicine, Ministry of Health, Riyadh
3MBBS, Hamdard College of Medicine and Dentistry, Hamdard University Hospital
4MBBS, M. Assistant, Musavvir Stem cell Clinic and Pathology Laboratory
5MBBS, MPH, Assistant Professor, Department of Community Medicine, Avicenna Medical College
6MBBS, Senior Medical officer, Community Health Services
7MBBS, House Officer, Liaquat National Hospital
8Pharm D, Hamdard University
9MBBS, Medical Officer, Ashfaq Memorial Hospital
10MBBS, M.Phil, Senior Lecturer Department of Physiology Al-Tibri Medical College Karachi
DOI: 10.15226/2374-8362/5/2/00155
Materials and Methods: A cross-sectional study was conducted with 372 patients aged 18 or above with self-reported history of hypertension and on anti-hypertensive medication. It was a multicenter study performed in urban health center and Myanmar health center for duration of 6 months from June 2017 till November 2017. Hypertension associated signs and symptoms were evaluated with the help of a questionnaire and clinical examination. Blood pressure was measured using sphygmomanometer with stethoscope.
Results: A higher percentage of males were smokers (18.2% vs. 1.4%) and gave a positive history of chest pain (49.3% vs. 38.2%), though a higher percentage of females gave a positive history of vision problems (57.0% vs. 49.3%), fatigue (74.8% vs. 70.3%) and confusion (66.7% vs. 60.6%). Moreover, a higher percentage of ≤40 years old patients gave a positive history of headache (80.7% vs. 69.4%) though a higher percentage of >40 years old patients were smokers (12.0% vs. 4.7%), gave a positive history of vertigo (59.3% vs. 47.7%), chest pain (49.3% vs. 32.2%), vision problems (57.4% vs. 44.2%), dyspnea (57.4% vs. 43.8%), increase in urinary frequency (45.5% vs. 30.6%), nausea (25.4% vs. 20.5%), sleep apnea (38.6% vs. 20.5%), irregular heartbeat/palpitation (39.9% vs. 33.0%), fatigue (74.8% vs. 67.0%) and confusion (68.6% vs. 52.3%).
Conclusion: The prevalence of smoking, chest pain, vision problems, fatigue and confusion were found to be different between both genders. Furthermore, the prevalence of smoking, headache, vertigo, chest pain, vision problems, dyspnea, increased urinary frequency, nausea, sleep apnea, irregular heartbeat/palpitation, fatigue and confusion were found to be different between both age groups.
Key words: Prevalence; Signs and Symptoms; Hypertension; Gender; Age
An analysis of global data revealed that the overall prevalence of hypertension is similar in both genders, and that it consistently increases with age worldwide. [5] A meta-analysis earlier reported 17% of the Pakistani population to be suffering from hypertension. [6] The World Health Organization recently estimated that 25.2% of the Pakistani population had high blood pressure. [7]
Hypertension is defined as a systolic blood pressure of ≥140 mm Hg, or a diastolic blood pressure of ≥90 mm Hg, or taking antihypertensive medication. [8] Hypertension can be of two types, essential and secondary. Essential hypertension can be defined as a rise in blood pressure of unknown cause that increases risk for cerebral, cardiac, and renal events. [9] Secondary hypertension is defined as increased systemic blood pressure due to an identifiable cause. [10]
Multiple factors such as age, gender, and level of high blood pressure can influence the way in which hypertension presents itself clinically but literature does not reveal substantial relevant data, both internationally and locally, making the task of assessing the effects of above mentioned factors in the clinical manifestation of hypertension difficult. Our objective therefore was to compare the prevalence of clinical signs and symptoms of hypertension among different gender and age based groups of hypertensive patients.
A detailed history was taken from each patient about hypertension associated symptoms with the help of a structured questionnaire. The questionnaire was designed based on 12 major or most frequently encountered symptoms by the hypertensive patients. The site, duration, and severity of each symptom were documented. Each symptom was graded from mild to severe to assess the severity of the symptoms. The presence of edema was noted with its laterality and grading. The appearance of chest pain was noted with its severity. The problems of vision were noted and classified according to the loss in field of vision. The history of epistaxis and urinary symptoms were noted with frequency. Few additional symptoms such as nausea, sleep apnea, palpitations, fatigue and confusion were also assessed subjectively. Blood pressure was measured using sphygmomanometer with stethoscope to assess hypertension level.
The collected data were coded, entered and analyzed on SPSS version 20. The descriptive analysis was performed by calculating means and standard deviations for continuous variables and frequencies and percentages for categorical variables. The duration of study was 6 months.
For gender wise comparison, the study results revealed that the mean age of male patients was slightly higher than that of female patients (50.36±11.93 years vs. 46.74±12.93 years) and therefore a higher percentage of them was above 40 years of age (79.9% vs. 60.0%). An almost equal percentage of both males and females had systolic hypertension (68.0% and 65.9% respectively) though the percentage of diastolic hypertension was slightly higher in females (53.1% vs. 48.1%). Both males and females had similar mean systolic blood pressure (141.13±13.94 mm Hg and 141.67±15.35 mm Hg respectively) though the mean diastolic blood pressure was slightly higher in females (86.09±9.65 mm Hg vs. 84.43±10.71 mm Hg). Both males and females had similar mean duration of hypertension as well (4.86±5.39 years and 4.78±5.39 years respectively). A much higher percentage of males were smokers (18.2% vs. 1.4%) though a slightly higher percentage of females gave a positive history of headache (75.3% vs. 70.8%). The mean duration of headache was found to be equal in both males and females (1.96±0.75 years and 1.96±0.68 years respectively) and the most common site of headache was similar in both genders as well i.e. complete headache (37.0% and 26.6% respectively). A majority of males reported their headache to be of moderate intensity whereas a majority of females reported it to be of severe intensity (53.7% and 41.4% respectively). An equal majority of both males and females gave a positive history of vertigo (55.0% and 55.9% respectively) and a majority of both genders reported it to be of mild intensity (60.4% and 65.0% respectively).An almost similar percentage of both males and females were found to have edema (40.5% and 43.0% respectively), a very high percentage of which was bilateral in both gender (84.6% and 80.4% respectively). The grading of bilateral edema of an almost similar percentage of both males and females was found to be severe (35.0% and 36.5% respectively). A higher percentage of males gave a positive history of chest pain (49.3% vs. 38.2%) though a higher percentage of females required a hospital visit for it to subside (16.4% vs. 5.4%). A higher percentage of females gave a positive history of vision problems (57.0% vs. 49.3%) though the most common type of vision problem was dark spots in field of vision in both males and females (47.9% and 45.0% respectively). A similar percentage of both males and females gave a positive history of dyspnea (53.0% and 52.7% respectively) and a majority of both genders reported it to be moderate in intensity (57.3% and 48.1% respectively). A very low percentage of both males and females gave a positive history of epistaxis (2.6% and 3.5% respectively). A slightly higher percentage of males reported an increase in urinary frequency (44.0% vs. 38.3%) though a majority of both males and females reported the change to be moderate (42.7% and 40.4% respectively). A slightly higher percentage of females gave a positive history of nausea (25.9% vs. 22.1%) whereas a slightly higher percentage of males gave a positive history of sleep apnea (34.2% vs. 32.0%). An almost similar percentage of both males and females gave a positive history of irregular heartbeat/ palpitation (38.3% and 37.0% respectively) though a higher percentage of females gave a positive history of both fatigue (74.8% vs. 70.3%) and confusion (66.7% vs. 60.6%) (Table 1).
Variables |
Males (n=156) |
Females (n=147) |
|
Frequency(%)/ Mean ± S.D. |
Frequency(%)/ Mean ± S.D. |
||
Age (Years) |
50.36 ± 11.93 |
46.74 ± 12.93 |
|
Age Group |
≤ 40 Years |
31(20.1) |
58(40.0) |
> 40 Years |
123(79.9) |
87(60.0) |
|
Systolic Blood Pressure |
Normotensive/ Prehypertensive |
50(32.0) |
50(34.1) |
Stage 1/Stage 2 Hypertensive |
106(68.0) |
97(65.9) |
|
Diastolic Blood Pressure |
Normotensive/ Prehypertensive |
81(51.9) |
69(46.9) |
Stage 1/Stage 2 Hypertensive |
75(48.1) |
78(53.1) |
|
Systolic Blood Pressure (mmHg) |
141.13 ± 13.94 |
141.67 ± 15.35 |
|
Diastolic Blood Pressure (mmHg) |
84.43 ± 10.71 |
86.09 ± 9.65 |
|
Hypertension Duration (Years) |
4.86 ± 5.39 |
4.78 ± 5.39 |
|
Smoking |
Yes |
28(18.2) |
2(1.4) |
No |
126(81.8) |
142(98.6) |
|
Headache |
Yes |
109(70.8) |
110(75.3) |
No |
45(29.2) |
36(24.7) |
|
Headache Duration (Years) |
1.96 ± 0.75 |
1.96 ± 0.68 |
|
Site of Headache |
Temporal |
5(4.6) |
18(16.5) |
Parietal |
17(15.7) |
12(11.0) |
|
Occipital |
27(25.0) |
24(22.0) |
|
Frontal |
19(17.6) |
26(23.9) |
|
Complete |
40(37.0) |
29(26.6) |
|
Intensity of Headache |
Mild |
25(23.1) |
28(25.3) |
Moderate |
58(53.7) |
37(33.3) |
|
Severe |
25(23.1) |
46(41.4) |
|
Vertigo |
Yes |
83(55.0) |
80(55.9) |
No |
68(45.0) |
63(44.1) |
|
Intensity of Vertigo |
Mild |
52(60.4) |
52(65.0) |
Moderate |
28(32.6) |
22(27.5) |
|
Severe |
6(7.0) |
6(7.5) |
|
Edema |
Yes |
60(40.5) |
58(43.0) |
No |
88(59.5) |
77(57.0) |
|
Laterality of Edema |
Bilateral |
44(84.6) |
45(80.4) |
Unilateral |
8(15.4) |
11(19.6) |
|
Grading of Bilateral Edema |
Mild |
16(26.7) |
10(15.9) |
Moderate |
23(38.3) |
30(47.6) |
|
Severe |
21(35.0) |
23(36.5) |
|
Chest Pain |
Yes |
75(49.3) |
55(38.2) |
No |
77(50.7) |
89(61.8) |
|
Severity of Chest Pain |
Improves with rest |
29(39.2) |
23(41.8) |
Needs pain relieving medication |
41(55.4) |
23(41.8) |
|
Requires hospital visit |
4(5.4) |
9(16.4) |
|
Vision Problems |
Yes |
75(49.3) |
81(57.0) |
No |
77(50.7) |
61(43.0) |
|
Type of Vision Problem |
Loss of central vision |
7(9.6) |
5(6.3) |
Loss of peripheral vision |
14(19.2) |
20(25.0) |
|
Dark spots in field of vision |
35(47.9) |
36(45.0) |
|
Pain in eyes |
17(23.3) |
19(23.8) |
|
Dyspnea |
Yes |
80(53.0) |
77(52.7) |
No |
71(47.0) |
69(47.3) |
|
Intensity of Dyspnea |
Mild |
14(17.1) |
13(16.8) |
Moderate |
47(57.3) |
37(48.1) |
|
Severe |
21(25.6) |
27(35.1) |
|
Epistaxis |
Yes |
4(2.6) |
5(3.5) |
No |
148(97.4) |
139(96.5) |
|
Increased Urinary Frequency |
Yes |
66(44.0) |
54(38.3) |
No |
84(56.0) |
87(61.7) |
|
Change in Urinary Frequency |
Mild |
25(33.3) |
17(29.8) |
Moderate |
32(42.7) |
23(40.4) |
|
Severe |
18(24.0) |
17(29.8) |
|
Nausea |
Yes |
34(22.1) |
38(25.9) |
No |
120(77.9) |
109(74.1) |
|
Sleep Apnea |
Yes |
53(34.2) |
47(32.0) |
No |
102(65.8) |
100(68.0) |
|
Irregular Heartbeat/Palpitation |
Yes |
59(38.3) |
54(37.0) |
No |
95(61.7) |
92(63.0) |
|
Fatigue |
Yes |
109(70.3) |
110(74.8) |
No |
46(29.7) |
37(25.2) |
|
Confusion |
Yes |
94(60.6) |
98(66.7) |
No |
61(39.4) |
49(33.3) |
Variables |
≤ 40 Years (n=89) |
>40 Years (n=210) |
|
Frequency(%)/ Mean ± S.D. |
Frequency(%)/ Mean ± S.D. |
||
Gender |
Male |
31(34.8) |
123(58.6) |
Female |
58(65.2) |
87(41.4) |
|
Systolic Blood Pressure |
Normotensive/ Prehypertensive |
42(47.2) |
58(27.6) |
Stage 1/Stage 2 Hypertensive |
47(52.8) |
152(72.4) |
|
Diastolic Blood Pressure |
Normotensive/ Prehypertensive |
45(50.5) |
105(50.0) |
Stage 1/Stage 2 Hypertensive |
44(49.5) |
105(50.0) |
|
Systolic Blood Pressure (mmHg) |
137.69 ± 14.70 |
142.85 ± 14.44 |
|
Diastolic Blood Pressure (mmHg) |
84.36 ± 9.47 |
85.46 ± 10.57 |
|
Hypertension Duration (Years) |
2.85 ± 3.74 |
5.66 ± 5.78 |
|
Smoking |
Yes |
4(4.7) |
25(12.0) |
No |
82(95.3) |
183(88.0) |
|
Headache |
Yes |
71(80.7) |
145(69.4) |
No |
17(19.3) |
64(30.6) |
|
Headache Duration (Years) |
1.87 ± 0.64 |
2.01 ± 0.74 |
|
Site of Headache |
Temporal |
7(10.1) |
16(11.1) |
Parietal |
6(8.8) |
23(16.0) |
|
Occipital |
19(27.5) |
28(19.4) |
|
Frontal |
18(26.1) |
27(18.8) |
|
Complete |
19(27.5) |
50(34.7) |
|
Intensity of Headache |
Mild |
23(32.9) |
30(20.7) |
Moderate |
25(35.7) |
68(46.9) |
|
Severe |
22(31.4) |
47(32.4) |
|
Vertigo |
Yes |
41(47.7) |
121(59.3) |
No |
45(52.3) |
83(40.7) |
|
Intensity of Vertigo |
Mild |
28(66.7) |
76(61.8) |
Moderate |
12(28.6) |
38(30.9) |
|
Severe |
2(4.8) |
9(7.3) |
|
Edema |
Yes |
33(40.2) |
84(42.6) |
No |
49(59.8) |
113(57.4) |
|
Laterality of Edema |
Bilateral |
23(76.7) |
66(84.6) |
Unilateral |
7(23.3) |
12(15.4) |
|
Grading of Bilateral Edema |
Mild |
6(17.1) |
20(23.0) |
Moderate |
16(45.7) |
36(41.4) |
|
Severe |
13(37.1) |
31(35.6) |
|
Chest Pain |
Yes |
28(32.2) |
101(49.3) |
No |
59(67.8) |
104(50.7) |
|
Severity of Chest Pain |
Improves with rest |
13(48.2) |
39(38.6) |
Needs pain relieving medication |
8(29.6) |
55(54.5) |
|
Requires hospital visit |
6(22.2) |
7(6.9) |
|
Vision Problems |
Yes |
38(44.2) |
117(57.4) |
No |
48(55.8) |
87(42.6) |
|
Type of Vision Problem |
Loss of central vision |
1(2.5) |
11(9.7) |
Loss of peripheral vision |
11(28.2) |
23(20.4) |
|
Dark spots in field of vision |
18(46.2) |
52(46.0) |
|
Pain in eyes |
9(23.1) |
27(23.9) |
|
Dyspnea |
Yes |
39(43.8) |
117(57.4) |
No |
50(56.2) |
87(42.6) |
|
Intensity of Dyspnea |
Mild |
9(22.0) |
18(15.4) |
Moderate |
20(48.8) |
63(53.8) |
|
Severe |
12(29.2) |
36(30.8) |
|
Epistaxis |
Yes |
2(2.4) |
7(3.4) |
No |
83(97.6) |
200(96.6) |
|
Increased Urinary Frequency |
Yes |
26(30.6) |
92(45.5) |
No |
59(69.4) |
110(54.5) |
|
Change in Urinary Frequency |
Mild |
10(33.3) |
32(32.0) |
Moderate |
11(36.7) |
44(44.0) |
|
Severe |
9(30.0) |
24(24.0) |
|
Nausea |
Yes |
18(20.5) |
53(25.4) |
No |
70(79.5) |
156(74.6) |
|
Sleep Apnea |
Yes |
18(20.5) |
81(38.6) |
No |
70(79.5) |
129(61.4) |
|
Irregular Heartbeat/Palpitation |
Yes |
29(33.0) |
83(39.9) |
No |
59(67.0) |
125(60.1) |
|
Fatigue |
Yes |
59(67.0) |
157(74.8) |
No |
29(33.0) |
53(25.2) |
|
Confusion |
Yes |
46(52.3) |
144(68.6) |
No |
42(47.7) |
66(31.4) |
The study results further revealed that a higher percentage of >40 years old patients were smokers whereas a higher percentage of ≤40 years old patients gave a positive history of headache. The mean duration of headache was found to be higher in >40 years old patients though the most common sites of headache were occipital and complete in both age groups. A higher percentage of patients in >40 years age group gave a positive history of vertigo and chest pain though a higher percentage of ≤40 years old patients required a hospital visit for their chest pain to subside. A higher percentage of >40 years old patients gave a positive history of vision problems though the most common type of vision problem was dark spots in field of vision in both age groups. A higher percentage of >40 years old patients gave a positive history of dyspnea and reported an increase in urinary frequency. A higher percentage of patients in >40 years age group gave a positive history of nausea, sleep apnea, irregular heartbeat/palpitation, fatigue and confusion as well.
The study results revealed that both males and females had almost equal levels of systolic and diastolic blood pressures, though Dustan HP in 1996 reported males to have higher blood pressure levels than females, albeit slightly. [11] Likewise, Daugherty SL et al., in 2011 also reported males to have lower rates of hypertension control than females. [12] This difference in findings could be a result of several factors, such as gender specific age structure and compliance rate of the populations in question. The study results further revealed that the patients in >40 years age group had higher levels of systolic and diastolic blood pressures, a finding well in line with published literature as Jo I et al., in 2001 also reported age to be associated with prevalence of hypertension. [13]
Moreover, a very high percentage of study participants gave a positive history of headache, irrespective of their gender or age. Similarly, D Tullio M et al., in 1988 also reported headache to be more prevalent in hypertensive than normotensive subjects. [14] Literature though reveals contrary findings as well as reported by Fuchs FD et al., in 2003 and Sherif SM et al., in 2012. [15,16] This difference in findings could well be attributed to different methodologies of the studies in question.
The study results further showed that vision problems were more prevalent among patients who were female or of older age in the study. Sherif SM et al., in 2012 did not report visual disturbances to be associated with hypertension, though without consideration for the gender or age of the study participants. [16] Furthermore, a higher percentage of >40 years old patients gave a positive history of dyspnea in the study. Karras DJ et al., in 2005 reported dyspnea to be associated with elevated blood pressure though irrespective of the age of the study participants. [17] Due to dearth of pertinent published literature, a meaningful comparison could not be made for the study findings mentioned above.
Moreover, a very low percentage of study participants gave a positive history of epistaxis, irrespective of their gender or age. Likewise, D Tullio M et al., in 1988 also did not find epistaxis to be associated with hypertension. [14] Furthermore, a very high percentage of study participants gave a positive history of fatigue, again irrespective of their gender or age. Unlike the study results though, D Tullio M et al., in 1988 did not report weakness to be associated with hypertension. [14] Due to lack of relevant published data, a comparison of the rest of study findings could not be made with the previous literature.
- He J, Whelton PK. Epidemiology and prevention of hypertension. Med Clin North Am. 1997; 81(5):1077-1097.
- Whelton PK. Epidemiology of hypertension. Lancet. 1994; 344(8915):101–106.
- World Health Day. WHO; 2013.
- Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ, Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 2002; 360(9343):1347-1360. DOI:10.1016/S0140-6736(02)11403-6
- Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365(9455):217-223. DOI:10.1016/S0140-6736(05)17741-1
- Neupane D, McLachlan CS, Sharma R, Gyawali B, Khanal V, Mishra SR, et al. Prevalence of hypertension in member countries of South Asian Association for Regional Cooperation (SAARC): systematic review and meta-analysis. Medicine. 2014; 93(13): e74. DOI:10.1097/MD.0000000000000074
- Non communicable Diseases Country Profile 2014. World Health Organization. 2014.
- Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012; 125(1):e2-220. DOI: 10.1161/CIR.0b013e31823ac046
- Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet. 2007; 370(9587):591-603. DOI:10.1016/S0140-6736(07)61299-9
- Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood pressure. 2013; 22(4):193-278. DOI:10.1097/01.hjh.0000431740.32696.cc
- Dustan HP. Gender differences in hypertension. J Hum Hypertens. 1996;10(6):337-340.
- Daugherty SL, Masoudi FA, Ellis JL, Ho PM, Schmittdiel JA, Tavel HM, et al. Age dependent gender differences in hypertension management. Journal of hypertension. 2011; 29(5):1005-1011. DOI:10.1097/HJH.0b013e3283449512
- Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C. Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study. Journal of hypertension. 2001; 19(9):1523-1532.
- Di Tullio M, Alli C, Avanzini F, Bettelli G, Colombo F, Devoto MA, et al. Prevalence of symptoms generally attributed to hypertension or its treatment: study on blood pressure in elderly outpatients (SPAA). Journal of hypertension. Supplement: official journal of the International Society of Hypertension. 1988; 6(1):S87-90.
- Fuchs FD, Gus M, Moreira LB, Moreira WD, Goncalves SC, Nunes G. Headache is not more frequent among patients with moderate to severe hypertension. Journal of human hypertension. 2003;17(11):787-790. DOI: 10.1038/sj.jhh.1001621
- Sherif SM, Ahmed ME, Homeida MM. Prevalence of hypertension in an urban community in Sudan. Khartoum Medical Journal. 2008;1(2): 72-74.
- Karras DJ, Ufberg JW, Harrigan RA, Wald DA, Botros MS, McNamara RM. Lack of relationship between hypertension-associated symptoms and blood pressure in hypertensive ED patients. Am J Emerg Med. 2005; 23(2):106-110.